Pfizer Inc. Share Price

Pfizer Inc. is a global company that finds, develops, produces, promotes, distributes, and sells biopharmaceutical pharmaceuticals in Europe and the US. With the Eliquis, Nurtec ODT/Vydura, Zavzpret, and Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; COVID-19 prevention and treatment, as well as potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands; and many other therapeutic areas, the company offers medications and vaccines.
It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. Additionally, the business engages in contract manufacturing.

In addition to pharmacies, individual provider offices, hospitals, clinics, government agencies, wholesalers, retailers, and integrated delivery systems are among its clients. The company is in collaboration agreements with Astellas Pharma US, Inc., BioNTech SE, Merck KGaA, and Bristol-Myers Squibb Company. Pfizer Inc.'s headquarters are in New York, where it was established in 1849.

The pfizer inc share price has approximately Beta of (5Y Monthly) is 0.63 as of 16 Aug 2024.